Resiliency Training for Patients With NF2 Via Videoconferencing With Skype
Completed · Not applicable
Conditions studied: Neurofibromatosis 2
In brief
The aim of this study is to determine, whether the 3RP is feasible, accepted and efficacious and durable when delivered via Skype to patients with neurofibromatosis type 2 (NF2) who are deaf or have severe hearing loss using Communication Access Realtime Translation (CART) and/or American Sign Language (ASL). This will be a substudy of the IRB-approved protocol #2013P002605. It is the same study except it is looking at a particular sub-population: patients with NF2 who are hard of hearing.
Key facts
- Study ID
- NCT02811718
- Run by
- Massachusetts General Hospital
- People needed
- 45
- Starts
- 2016-07-01
- Expected to finish
- 2018-07-01
- Last updated by the study team
- 2018-08-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 or older
- Can read and speak English at or above the 6th grade level
- Patients with NF2 who are deaf or have severe hearing loss.
You may not qualify if…
- Severe active or untreated major mental illness that would interfere with study participation, to be determined at the discretion of the study investigator (e.g. untreated psychosis or suicidality)
- Recent (within past 3 months) change in antidepressant medication
- Use of formal relaxation training (including past participation in a mind-body program), currently or in the past 6 months.
- Unable or unwilling to sign the informed consent documents
- Unable or unwilling to complete psychological assessments online via the REDCap system.
- Unable or unwilling to participate in an intervention delivered via videoconferencing with Skype.
- Unwilling to use either CART or ASL for communication during the Skype groups.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.